Report: Lupin stands to benefit from drug patent expiries
NEW YORK — A wave of patent expirations over the next several years will open up a broad swath of drugs to generic competition, and India’s Lupin Pharmaceuticals is looking to benefit, according to published reports.
The Wall Street Journal reported that the Mumbai-based company planned to launch 25 to 30 new generic drugs each year over the next couple of years.
These include contraceptives, as well as antipsychotics and diabetes drugs, according to the article. In September alone, the company received Food and Drug Administration approval for generic versions of Watson’s contraceptive NOR-QD (norethindrone) tablets and launched versions of UCB’s epilepsy drug Keppra (levetiracetam) and Shionogi’s painkiller Ponstel (mefenamic acid).
Teva, The Medicines Co. settle suit over blood-thinning drug
PARSIPPANY, N.J. — The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO’s drugs by the end of the decade.
The drug makers announced the settlement in the U.S. District Court for the District of Delaware, whereby Teva can launch a generic version of the injectable anticoagulant drug Angiomax (bivalirudin) in June 2019.
Under the settlement, Teva admits that two patents covering Angiomax are valid, enforceable and would be infringed by Teva’s generic version. The patents are scheduled to expire in July 2028, according to the Food and Drug Administration. MDCO remains in infringement litigation concerning the drug with generic drug makers APP Pharmaceuticals, Hospira, Mylan and Dr. Reddy’s Labs.
In-store marketing gets a new taste at Albertsons
SAN DIEGO — Consumers are busier than ever and are inclined to spend as little time shopping for groceries as possible, so attracting them enough to stop and sample a new product is a challenge. Albertsons is looking to address that issue by teaming with Daymon Interactions, a consumer event marketing company, to develop a new in-house product sampling and event marketing program.
"A Taste of Albertsons" is designed to connect shoppers with vendors through personalized product sampling events, Daymon noted in a press release. The in-store events began Oct. 1, and throughout the first year of operation, A Taste of Albertsons will be featured throughout the United States in Arizona, Texas, New Mexico and Colorado. According to the company, these events will focus on sampling, product launches, holiday promotions, meal-solutions and more. A dedicated sales staff will be on hand to engage customers as well.
“Through this new and dynamic shopping experience, we are able to better serve and bring more value to Albertsons and our vendor partners,” said Daymon Interactions business manager Denise Decker, who will lead the Albertsons account. “Daymon Interactions has a fresh and engaging way to approach in-store events and I think shoppers will respond positively.”